Virtus ETF Advisers’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,333
| Closed | -$57.6K | – | 418 |
|
|
2024
Q4 | $57.6K | Buy |
10,333
+6,560
| +174% | +$36.5K | 0.02% | 454 |
|
|
2024
Q3 | $40.8K | Buy |
3,773
+64
| +2% | +$692 | 0.02% | 446 |
|
|
2024
Q2 | $77.9K | Sell |
3,709
-1,506
| -29% | -$31.6K | 0.04% | 415 |
|
|
2024
Q1 | $166K | Sell |
5,215
-359
| -6% | -$11.4K | 0.09% | 310 |
|
|
2023
Q4 | $113K | Buy |
5,574
+1,095
| +24% | +$22.2K | 0.07% | 325 |
|
|
2023
Q3 | $57K | Sell |
4,479
-444
| -9% | -$5.65K | 0.03% | 408 |
|
|
2023
Q2 | $89K | Buy |
4,923
+783
| +19% | +$14.1K | 0.05% | 417 |
|
|
2023
Q1 | $71.2K | Sell |
4,140
-1,591
| -28% | -$27.3K | 0.04% | 401 |
|
|
2022
Q4 | $127K | Buy |
+5,731
| New | +$127K | 0.07% | 398 |
|
|
2022
Q2 | – | Sell |
-7,683
| Closed | -$116K | – | 455 |
|
|
2022
Q1 | $116K | Sell |
7,683
-457
| -6% | -$6.9K | 0.05% | 274 |
|
|
2021
Q4 | $179K | Buy |
8,140
+883
| +12% | +$19.4K | 0.07% | 249 |
|
|
2021
Q3 | $196K | Sell |
7,257
-385
| -5% | -$10.4K | 0.09% | 275 |
|
|
2021
Q2 | $184K | Buy |
+7,642
| New | +$184K | 0.08% | 380 |
|